Why is Apogee Therapeutics, Inc. stock up today?

June 23, 2026

Apogee Therapeutics, Inc.

APGE · NGM · USD

$132.93

▲ 0.38 (0.29%)

vs. prev. close $132.55

Last updated Jun 23, 2026 15:13

Intraday Chart — 5-min intervals

📊

AI Summary

APGE · less than a minute ago

cached

Apogee Therapeutics, Inc. edges higher 0.29% — Zacks reports

Apogee Therapeutics, Inc. (APGE) is holding steady with a slight gain, at $132. 93 — up 0. 29% from yesterday's close of $132. 55. Today's move appears driven by recent headlines, including "Company News for Jun 23, 2026" and "Guggenheim Downgrades Apogee Therapeutics to Neutral From Buy". News sentiment around APGE is leaning negative.

The broader market is under pressure (S&P 500: -1. 1%, Nasdaq: -1. 7%, Dow Jones: +0. 0%, Shanghai: +1. 8%, Hang Seng: -1. 8%). Past performance does not guarantee future results.

Key Factors

1Company News for Jun 23, 2026

2📉 Guggenheim Downgrades Apogee Therapeutics to Neutral From Buy

33 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

4🌐 Broad market: S&P 500: -1.1%, Nasdaq: -1.7%, Dow Jones: +0.0%, Shanghai: +1.8%, Hang Seng: -1.8%

Auto-generated analysis · Not financial advice

less than a minute ago

📰Recent News

6 neutral2 negative

⚠️ Disclaimer: The information on this page is for informational purposes only and does not constitute financial advice. AI-generated summaries may be inaccurate. Always conduct your own research and consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.

🌐Market ContextRisk-Off 📉

S&P 500

-1.13%

Nasdaq

-1.73%

Dow Jones

+0.01%

Shanghai

+1.78%

Hang Seng

-1.82%

Nikkei 225

-3.55%

FTSE 100

+0.19%

Nifty 50

-1.16%

DAX

-0.74%

OMX Stockholm

-0.82%

Search another stock